Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, March 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 5,511 followers.

RT @GrupoPKgen_SEFH: #Pharmacokinetic pharmacodynamic of #teicoplanin in MRSA infections: AUC24/MIC ratio of ≥900 µg·h/mL is required https…

RT @GrupoPKgen_SEFH: #Pharmacokinetic pharmacodynamic of #teicoplanin in MRSA infections: AUC24/MIC ratio of ≥900 µg·h/mL is required https…

#Pharmacokinetic pharmacodynamic of #teicoplanin in MRSA infections: AUC24/MIC ratio of ≥900 µg·h/mL is required https://t.co/e7xASiUFgm

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections. - PubMed - NCBI https://t.co/BurKeHXSVI #mrsa

Analysis of teicoplanin in patients with MRSA: Matsumoto K, Watanabe E, Kanazawa N, Fukamizu T, Shigemi A, Yok... https://t.co/rX9AlhzLeX